Analysis of marketing authorization holder (MAH) pilot program in Jiangsu province and policy suggestionsBAI Geng-liang, YAO Song-mei, YANG Yong2687-2692
Discussion on the design of bioequivalence study for highly variable drugsSU Jing, LIU Ya-li2693-2697
Study on the mechanism of anti-PM2.s effect of Ershiwuwei Feibing pillsCHEN Wei-wu, ZHOU Sheng-jun, HUANG Yan-feng, CI Wang-Jiu-mei, PENG Yi, CHEN Lun-ju2702-2708
The establishment of 3D HepaRG spheroid modelLI Xiao-xu, MENG Zhen-kai, RONG Bin, WU Chun-qi, GUO Shang-jing, WANG Quan-jun2709-2717
Progress in the detection method of replication-competent lentivirusCUI Jing, WEI Wei, LUO Jian-hui2718-2723
Interpretation of EUCAST breakpoints for rapid antimicrobial susceptibility testing directly from blood cultureFAN Xin, HUANG Jing-jing, XU Ying-chun, YANG Qi-wen, FENG Xian-ju2724-2728
Clinical observation of efficacy and safety of hepatocyte growth-promoting factor (pHGF) for injection in the treatment of acute and chronic hepatitisXIE Ying, XU Wen-sheng, GAO Yue-qiu, SHANG Bin-yi, NI Liu-da, ZHANG Shao-ying, TENG Fei, WANG Bo2729-2734
Efficacy of intermittent repetitive levosimendan treatment in patients with advanced heart failure complicated with renal dysfunctionWANG Wen-yan, LI Xiao-dong, WU Xin, YUAN Xiao-mei, KONG Hong2735-2740